13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 65 holding rows worth $660,559,000.
- Accession
- 0001802630-21-000003
- Filer
- CIK 1802630
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 65 entries on the cover page, a total value of $660,559,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $660,558,000 with VALUE read as thousands by filing date, 13F file number 028-20043. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 2,825,000 | $397,704,000 | thousands by filing date | put |
| BIOATLA INC | 09077B104 | COM | 1,055,557 | $35,899,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,375,681 | $28,342,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,597,279 | $11,037,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 742,085 | $10,011,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 268,548 | $8,897,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 8,500,000 | $8,675,000 | thousands by filing date | principal |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 558,117 | $8,584,000 | thousands by filing date | |
| GALECTO INC | 36322Q107 | COM | 649,600 | $8,126,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 390,847 | $7,844,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 74,189 | $7,383,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 236,589 | $7,305,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 213,807 | $7,049,000 | thousands by filing date | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 303,998 | $6,931,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 199,867 | $6,182,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 401,606 | $5,739,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 206,844 | $5,504,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 107,826 | $4,997,000 | thousands by filing date | |
| VESPER HEALTHCARE ACQSTN COR | 92538T104 | COM CL A | 416,551 | $4,711,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 24,999 | $4,326,000 | thousands by filing date | |
| OAKTREE ACQUISITION CORP | G67145105 | SHS CL A | 281,565 | $4,111,000 | thousands by filing date | |
| Surmodics Inc | 868873100 | Common Stock | 92,975 | $4,046,000 | thousands by filing date | |
| Misonix Inc | 604871103 | COM | 301,333 | $3,767,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 64,284 | $3,214,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 8,165 | $3,018,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 18,938 | $2,959,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 140,524 | $2,791,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 66,921 | $2,519,000 | thousands by filing date | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 2,750,000 | $2,477,000 | thousands by filing date | principal |
| NEOGENOMICS INC | 64049M209 | COM NEW | 45,951 | $2,474,000 | thousands by filing date | |
| Rafael Holdings Inc Class B | 75062E106 | COM | 104,737 | $2,442,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 28,406 | $2,324,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 19,013 | $2,317,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 21,477 | $2,301,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 185,719 | $2,282,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 42,743 | $2,036,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 56,422 | $1,824,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 105,941 | $1,795,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 7,838 | $1,722,000 | thousands by filing date | |
| OAK STR HEALTH INC | 67181A107 | COM | 27,612 | $1,689,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 9,589 | $1,660,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 10,825 | $1,657,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 103,819 | $1,527,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 135,992 | $1,474,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 336,442 | $1,396,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E202 | COM NEW | 81,185 | $1,335,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 500,000 | $1,250,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 24,484 | $1,188,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 22,631 | $1,070,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 56,909 | $1,024,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 3,899 | $955,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 12,655 | $926,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 31,136 | $882,000 | thousands by filing date | |
| MEDICENNA THERAPEUTICS F | 58490H107 | FOREIGN CANADIAN | 186,799 | $874,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 74,120 | $845,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 13,116 | $813,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 7,661 | $657,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 10,423 | $625,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 6,830 | $621,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 33,813 | $605,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 41,064 | $517,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 16,093 | $390,000 | thousands by filing date | |
| OAKTREE ACQUISITION CORP | G67145113 | *W EXP 99/99/999 | 91,793 | $358,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 7,024 | $294,000 | thousands by filing date | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 3,300 | $261,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-21-000003 | this filing | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001802630-21-000006 | base | 2021-04-29 | acceptance time not in the bulk data set |